البحث عن طبيب

Erinn P. Downs, D.O.

طلب موعد

المنشورات

  1. Duckworth LA, Bakhshwin A, Reith J, Downs E, McIntire PJ. Malignant Phyllodes Tumor with Heterologous Telangiectatic Osteosarcoma. Int J Surg Pathol. 2024 Feb 1; 10668969241228287 Epub 2024 Feb 01
    View PubMed
  2. Hoda RS, Duckworth LA, Gilmore HL, Cui X, McIntire PJ, Sciallis AP, Van Arnam JS, Zhang G, Rowe JJ, Xiao H, Azzato EM, Goldblum JR, Fritchie K, Downs EP. Solitary Fibrous Tumor of Breast and Axilla: Clinicopathological Profile of Five Tumors With Comparison of Risk Stratification Models. Int J Surg Pathol. 2023 Oct 30; 10668969231204957 [Epub ahead of print]
    View PubMed
  3. Caputo A, Vipparthi K, Bazeley P, Downs-Kelly E, McIntire P, Duckworth LA, Ni Y, Hu B, Keri RA, Karaayvaz M. Spatial transcriptomics suggests that alterations occur in the preneoplastic breast microenvironment of BRCA1/2 mutation carriers. Mol Cancer Res. 2023 Oct 25 [Epub ahead of print]
    View PubMed
  4. Harper LK, Carnahan MB, Bhatt AA, Simmons CL, Patel BK, Downs E, Pockaj BA, Yancey K, Eversman SE, Sharpe RE. Imaging Characteristics of and Multidisciplinary Management Considerations for Atypical Ductal Hyperplasia and Flat Epithelial Atypia: Review of Current Literature. Radiographics. 2023 Oct; 43 (10):e230016
    View PubMed
  5. Mulkearns-Hubert EE, Esakov Rhoades E, Ben-Salem S, Bharti R, Hajdari N, Johnson S, Myers A, Smith IN, Bandyopadhyay S, Eng C, Downs E, Lathia JD, Reizes O. Targeting NANOG and FAK via Cx26-derived cell-penetrating peptides in triple-negative breast cancer. Mol Cancer Ther. 2023 Sep 13 Epub 2023 Sept 13
    View PubMed
  6. Lewis G, Fong N, Gjeorgjievski SG, Li XB, Li Z, Wei S, Sturgis CD, Wang C, Komforti M, Zhang H, Downs E, Cui X, McIntire P, Hoda RS, Rowe JJ, Sciallis A, Zhang G. Low-grade adenosquamous carcinoma of the breast: a clinical, morphological and immunohistochemical analysis of 25 patients. Histopathology. 2023 Aug; 83(2):252-263. Epub 2023 Apr 17.
    View PubMed
  7. Komforti M, Downs-Kelly E, Sapunar F, Wijayawardana SR, Gruver AM, Badve SS. Two Instrument Comparison of Reagents From a US FDA-Approved Assay for the Assessment of Ki-67 in High-Risk Early Breast Cancer. Appl Immunohistochem Mol Morphol. 2022 Sep 1; 30 (8):577-583 Epub 2022 July 27
    View PubMed
  8. Duckworth LA, Hoda R, Komforti MK, Rowe JJ, Downs-Kelly E, McIntire PJ. Re-Classification with Outcome Correlation of Previously Diagnosed Malignant Phyllodes Tumors Applying the 2016 Consensus Guidelines. Int J Surg Pathol. 2022 Jul 3; 10668969221106105 Epub 2022 July 03
    View PubMed
  9. Gulbahce HE, Downs-Kelly E, Herget KA, Stoddard GJ. The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer. Arch Pathol Lab Med. 2022 Apr 1; 146 (4):478-484
    View PubMed
  10. Duckworth LA, Cotta CV, Rowe JJ, Downs-Kelly E, Komforti MK. Amyloid in the breast: retrospective review with clinicopathological and radiological correlation of 32 cases from a single institution. Histopathology. 2021 Jul; 79 (1):57-66 Epub 2021 May 06
    View PubMed
  11. Tzeng A, Sangwan N, Jia M, Liu CC, Keslar KS, Downs-Kelly E, Fairchild RL, Al-Hilli Z, Grobmyer SR, Eng C. Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer. Genome Med. 2021 Apr 16; 13 (1):60
    View PubMed
  12. Demkowicz R, Thota PN, Benjamin T, Lopez R, Lu H, Patil DT, Downs-Kelly E, Jeung JA, Lai KK, Lapinski J, Savage EC, Goldblum JR, Gordon IO. Allaying uncertainty in diagnosing buried Barrett's esophagus. Ann Diagn Pathol. 2021 Apr; 51:151672 Epub 2020 Nov 27
    View PubMed
  13. Shetty S, Sharma N, Booth CN, Oshilaja O, Downs-Kelly EP, McKenney JK, Sturgis CD. Mammary Extranodal Rosai-Dorfman Disease With and Without Associated Axillary Lymphadenopathy: Insights for Practitioners of Breast Pathology. Int J Surg Pathol. 2020 Aug; 28 (5):541-548 Epub 2020 Jan 28
    View PubMed
  14. Clinton LK, Plesec T, Goldblum JR, Hajifathalian K, Downs-Kelly E, Patil DT. Specific Histopathologic Features Aid in Distinguishing Diffuse-type Gastric Adenocarcinoma From Metastatic Lobular Breast Carcinoma. Am J Surg Pathol. 2020 Jan; 44 (1):77-86
    View PubMed
  15. Park DY, Krishnamurthi S, Chahal P, Downs-Kelly E, Morris-Stiff G. Pancreatic metastases to the colon: an unusual cause of colonic obstruction. BMJ Case Rep. 2019 Nov 26; 12 (11)
    View PubMed
  16. Khattab RA, Rowe JJ, Booth CN, Sneige N, Fong N, Pantanowitz L, Oshilaja O, Brainard JA, Downs-Kelly EP, Dawson A, Sturgis CD. Mammary mesenchymal and fibroepithelial lesions: An illustrated cytomorphologic update with differential diagnoses. Diagn Cytopathol. 2019 Oct; 47 (10):1100-1118 Epub 2019 July 25
    View PubMed
  17. Kutty GR, Downs-Kelly E, Crispin HT, Peterson KA. Elevated Tryptase in EoE Is an Independent Phenomenon Associated with Extra-Esophageal Symptoms. Dig Dis Sci. 2019 Jan; 64 (1):152-157 Epub 2018 Sept 28
    View PubMed
  18. Gautham I, Radford DM, Kovacs CS, Calhoun BC, Procop GW, Shepardson LB, Dawson AE, Downs-Kelly EP, Zhang GX, Al-Hilli Z, Fanning AA, Wilson DA, Sturgis CD. Cystic neutrophilic granulomatous mastitis: The Cleveland Clinic experience with diagnosis and management. Breast J. 2019 Jan; 25 (1):80-85 Epub 2018 Nov 17
    View PubMed
  19. Bruehl FK, Cooper KL, Kilpatrick SE, Weindel MD, Ganea M, Astbury C, Downs-Kelly EP, Sturgis CD. Intramammary Angiomatoid Fibrous Histiocytoma, a Rare EWSR1 Rearranged Mesenchymal Neoplasm in a Previously Unreported Anatomic Location with Review of the Cleveland Clinic Experience. Case Rep Pathol. 2019; 2019:9012878 Epub 2019 May 20
    View PubMed
  20. Hashemi-Sadraei N, Muller-Greven GM, Abdul-Karim FW, Ulasov I, Downs-Kelly E, Burgett ME, Lauko A, Qadan MA, Weil RJ, Ahluwalia MS, Du L, Prayson RA, Chao ST, Budd TG, Barnholtz-Sloan J, Nowacki AS, Keri RA, Gladson CL. Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer. J Neurooncol. 2018 Nov; 140 (2):237-248 Epub 2018 Aug 09
    View PubMed
  21. Garlick JW, Olson KA, Downs-Kelly E, Bucher BT, Matsen CB. Secretory breast carcinoma in an 8-year-old girl: A case report and literature review. Breast J. 2018 Nov; 24 (6):1055-1061 Epub 2018 Sept 24
    View PubMed
  22. Boylan KE, Larsen BT, Young BA, Downs-Kelly E, Panchabhai TS, Collum ES, Jensen L, Emerson LL. Pulmonary Mycobacterial Spindle Cell Pseudotumor: A Report of 3 Cases Including a Practical Approach to Histopathologic Recognition of This Unusual Entity. Int J Surg Pathol. 2018 Oct; 26 (7):629-634 Epub 2018 May 02
    View PubMed
  23. Varedi D, Kovacsovics T, Downs Kelly E, Abraham J, Cowley J, Barrell K, Revelo MP, Stehlik J, Drakos S, Marrouche N, Wilson B, Swanson EA, Fang J, Nativi-Nicolau J. Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging. Circ Heart Fail. 2018 Jul; 11(7):e004812.
    View PubMed
  24. Stewart RL, Gulbahce EH, Geiersbach KB, Downs-Kelly E. Reply to Commentary on 'HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features'. Mod Pathol 2018 Apr; 31 (4):686
    View PubMed
  25. Caliskan A, Kohlmann WK, Affolter KE, Downs-Kelly E, Kanth P, Bronner MP. Intramucosal lipomas of the colon implicate Cowden syndrome. Mod Pathol. 2018 Apr; 31 (4):643-651 Epub 2017 Dec 01
    View PubMed
  26. Stewart RL, Caron JE, Gulbahce EH, Factor RE, Geiersbach KB, Downs-Kelly E. HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features. Mod Pathol. 2017 Nov; 30 (11):1561-1566 Epub 2017 July 28
    View PubMed
  27. Affolter K, Samowitz W, Boynton K, Kelly ED. Doxycycline-induced gastrointestinal injury. Hum Pathol. 2017 Aug; 66:212-215 Epub 2017 Mar 09
    View PubMed
  28. Lloyd IE, Kohlmann WK, Gligorich K, Hall A, Lyon E, Downs-Kelly E, Samowitz WS, Bronner MP. A Clinicopathologic Evaluation of Incidental Fundic Gland Polyps With Dysplasia: Implications for Clinical Management. Am J Gastroenterol. 2017 Jul; 112 (7):1094-1102 Epub 2017 May 02
    View PubMed
  29. Donaldson AR, Shetty S, Wang Z, Rivera CL, Portier BP, Budd GT, Downs-Kelly E, Lanigan CP, Calhoun BC. Impact of an alternative chromosome 17 probe and the 2013 American Society of Clinical Oncology and College of American Pathologists guidelines on fluorescence in situ hybridization for the determination of HER2 gene amplification in breast cancer. Cancer. 2017 Jun 15; 123 (12):2230-2239 Epub 2017 Feb 13
    View PubMed
  30. Daniels BH, Ko JS, Rowe JJ, Downs-Kelly E, Billings SD. Radiation-associated angiosarcoma in the setting of breast cancer mimicking radiation dermatitis: A diagnostic pitfall. J Cutan Pathol. 2017 May; 44 (5):456-461 Epub 2017 Feb 21
    View PubMed
  31. Johnson ED, Downs-Kelly E, Bull DA, Gulbahce HE. Primary Cystic Pleuropulmonary Synovial Sarcoma Presenting as Recurrent Pneumothorax. Case Rep Oncol. 2017 May-Aug; 10 (2):660-665 Epub 2017 July 14
    View PubMed
  32. Hui L, Geiersbach KB, Downs-Kelly E, Gulbahce HE. RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference Laboratory. Arch Pathol Lab Med. 2017 Feb; 141 (2):274-278 Epub 2016 Dec 13
    View PubMed
  33. Calhoun BC, Collie AM, Lott-Limbach AA, Udoji EN, Sieck LR, Booth CN, Downs-Kelly E. Lobular neoplasia diagnosed on breast Core biopsy: frequency of carcinoma on excision and implications for management. Ann Diagn Pathol. 2016 Dec; 25:20-25. Epub 2016 Aug 18.
    View PubMed
  34. Willmore-Payne C, Damjanovich-Colmenares K, Pasi AV, Werner TL, Gulbahce HE, Downs-Kelly E, Geiersbach KB. Inconsistent Results With Different Secondary Reflex Assays for Resolving HER2 Status. Am J Clin Pathol. 2016 Nov 1; 146 (5):618-626
    View PubMed
  35. Geiersbach KB, Willmore-Payne C, Pasi AV, Paxton CN, Werner TL, Xu X, Wittwer CT, Gulbahce HE, Downs-Kelly E. Genomic Copy Number Analysis of HER2-Equivocal Breast Cancers. Am J Clin Pathol. 2016 Oct; 146 (4):439-47 Epub 2016 Sept 10
    View PubMed
  36. Patil DT, Kissiedu J, Rodriguez ER, Downs-Kelly E, Liu X, Rybicki LA, Tan CD. Mesenteric Arteriovenous Dysplasia/Vasculopathy Is Distinct From Fibromuscular Dysplasia. Am J Surg Pathol. 2016 Oct; 40 (10):1316-25
    View PubMed
  37. Zhang G, Lanigan CP, Goldblum JR, Tubbs RR, Downs-Kelly E. Automated Bright-Field Dual-Color In Situ Hybridization for MDM2: Interobserver Reproducibility and Correlation With Fluorescence In Situ Hybridization in a Series of Soft Tissue Consults. Arch Pathol Lab Med. 2016 Oct; 140 (10):1111-5
    View PubMed
  38. Tuohy VK, Jaini R, Johnson JM, Loya MG, Wilk D, Downs-Kelly E, Mazumder S. Targeted Vaccination against Human alpha-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer. Cancers (Basel). 2016 Jun 16; 8 (6) Epub 2016 June 16
    View PubMed
  39. Forero A, Li Y, Chen D, Grizzle WE, Updike KL, Merz ND, Downs-Kelly E, Burwell TC, Vaklavas C, Buchsbaum DJ, Myers RM, LoBuglio AF, Varley KE. Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes. Cancer Immunol Res. 2016 May; 4 (5):390-9 Epub 2016 Mar 15
    View PubMed
  40. Geiersbach K, Adey N, Welker N, Elsberry D, Malmberg E, Edwards S, Downs-Kelly E, Salama M, Bronner M. Digitally guided microdissection aids somatic mutation detection in difficult to dissect tumors. Cancer Genet. 2016 Jan-Feb; 209 (1-2):42-9 Epub 2015 Dec 15
    View PubMed
  41. Frech TM, Boynton K, Downs-Kelly E, Jones B, Kriesel JD, Peterson K. Eosinophilic Esophagitis in Two Patients with Systemic Sclerosis. Case Rep Rheumatol. 2016; 2016:6410421 Epub 2016 Jan 20
    View PubMed
  42. Peintinger F, Sinn B, Hatzis C, Albarracin C, Downs-Kelly E, Morkowski J, Gould R, Symmans WF. Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy. Mod Pathol. 2015 Jul; 28 (7):913-20 Epub 2015 May 01
    View PubMed
  43. Harness JK, Giuliano AE, Pockaj BA, Downs-Kelly E. Margins: a status report from the Annual Meeting of the American Society of Breast Surgeons. Ann Surg Oncol. 2014 Oct; 21 (10):3192-7 Epub 2014 Aug 01
    View PubMed
  44. Roma AA, Downs-Kelly E. Reliability of PAX8 in clinical practice to accurately determine primary site of origin in female pelvic or abdominal lesions. Ann Diagn Pathol. 2014 Aug; 18 (4):227-31 Epub 2014 Apr 13
    View PubMed
  45. Sossey-Alaoui K, Pluskota E, Davuluri G, Bialkowska K, Das M, Szpak D, Lindner DJ, Downs-Kelly E, Thompson CL, Plow EF. Kindlin-3 enhances breast cancer progression and metastasis by activating Twist-mediated angiogenesis. FASEB J. 2014 May; 28 (5):2260-71 Epub 2014 Jan 27
    View PubMed
  46. Pai RK, Hartman DJ, Gonzalo DH, Lai KK, Downs-Kelly E, Goldblum JR, Liu X, Patil DT, Bennett AE, Plesec TP, Kuan SF, Nikiforova MN, Shadrach B, Pai RK. Serrated lesions of the appendix frequently harbor KRAS mutations and not BRAF mutations indicating a distinctly different serrated neoplastic pathway in the appendix. Hum Pathol. 2014 Feb; 45 (2):227-35 Epub 2013 Oct 30
    View PubMed
  47. Portier BP, Minca EC, Wang Z, Lanigan C, Gruver AM, Downs-Kelly E, Budd GT, Tubbs RR. HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma. Oncotarget. 2013 Oct; 4 (10):1662-72
    View PubMed
  48. Gonzalo DH, Lai KK, Shadrach B, Goldblum JR, Bennett AE, Downs-Kelly E, Liu X, Henricks W, Patil DT, Carver P, Na J, Gopalan B, Rybicki L, Pai RK. Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma/polyp. J Pathol. 2013 Aug; 230 (4):420-9
    View PubMed
  49. Nizialek EA, Peterson C, Mester JL, Downes-Kelly E, Eng C. Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest. Hum Mol Genet. 2013 Jun 15; 22 (12):2451-61 Epub 2013 Feb 27
    View PubMed
  50. Mahajan D, Downs-Kelly E, Liu X, Pai RK, Patil DT, Rybicki L, Bennett AE, Plesec T, Cummings O, Rex D, Goldblum JR. Reproducibility of the villous component and high-grade dysplasia in colorectal adenomas <1 cm: implications for endoscopic surveillance. Am J Surg Pathol. 2013 Mar; 37 (3):427-33
    View PubMed
  51. Portier BP, Wang Z, Downs-Kelly E, Rowe JJ, Patil D, Lanigan C, Budd GT, Hicks DG, Rimm DL, Tubbs RR. Delay to formalin fixation 'cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry. Mod Pathol. 2013 Jan; 26 (1):1-9 Epub 2012 Aug 17
    View PubMed
  52. Cheriyath V, Kuhns MA, Jacobs BS, Evangelista P, Elson P, Downs-Kelly E, Tubbs R, Borden EC. G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer. Oncogene. 2012 Apr 26; 31 (17):2222-36 Epub 2011 Sept 26
    View PubMed
  53. Navaneethan U, Venkatesh PG, Downs-Kelly E, Shen B. Isospora belli superinfection in a patient with eosinophilic gastroenteritis--a diagnostic challenge. J Crohns Colitis. 2012 Mar; 6 (2):236-9 Epub 2011 Sept 16
    View PubMed
  54. Tan MH, De S, Bebek G, Orloff MS, Wesolowski R, Downs-Kelly E, Budd GT, Stark GR, Eng C. Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer. Breast Cancer Res Treat. 2012 Feb; 131 (3):849-58 Epub 2011 Apr 09
    View PubMed
  55. Landau M, Goldblum JR, DeRoche T, Dumot J, Downs-Kelly E, Rice TW, Xiao SY, Liu X. Esophageal carcinoma cuniculatum: report of 9 cases. Am J Surg Pathol. 2012 Jan; 36 (1):8-17
    View PubMed
  56. Patil DT, Goldblum JR, Rybicki L, Plesec TP, Mendelin JE, Bennett AE, Castilla EA, Henricks WH, Schoenfield L, Skacel M, Yerian LM, Rice TW, Bronner MP, Downs-Kelly E. Prediction of adenocarcinoma in esophagectomy specimens based upon analysis of preresection biopsies of Barrett esophagus with at least high-grade dysplasia: a comparison of 2 systems. Am J Surg Pathol. 2012 Jan; 36 (1):134-41
    View PubMed
  57. Morrison J, Bronner M, Leach BH, Downs-Kelly E, Goldblum JR, Liu X. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach. Scand J Gastroenterol. 2011 Nov; 46 (11):1340-8 Epub 2011 Aug 31
    View PubMed
  58. Sossey-Alaoui K, Downs-Kelly E, Das M, Izem L, Tubbs R, Plow EF. WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade. Int J Cancer. 2011 Sep 15; 129 (6):1331-43 Epub 2011 Mar 22
    View PubMed
  59. Zheng Q, Dunlap SM, Zhu J, Downs-Kelly E, Rich J, Hursting SD, Berger NA, Reizes O. Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. Endocr Relat Cancer. 2011 Aug; 18 (4):491-503 Epub 2011 July 11
    View PubMed
  60. Downs-Kelly E, Bell D, Perkins GH, Sneige N, Middleton LP. Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ. Arch Pathol Lab Med. 2011 Jun; 135 (6):737-43
    View PubMed
  61. Patel RM, Downs-Kelly E, Dandekar MN, Fanburg-Smith JC, Billings SD, Tubbs RR, Goldblum JR. FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool. Am J Dermatopathol. 2011 Apr; 33 (2):140-3
    View PubMed
  62. Tanas MR, Rubin BP, Tubbs RR, Billings SD, Downs-Kelly E, Goldblum JR. Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience. Arch Pathol Lab Med. 2010 Dec; 134 (12):1797-803
    View PubMed
  63. Papouchado BG, Myles J, Lloyd RV, Stoler M, Oliveira AM, Downs-Kelly E, Morey A, Bilous M, Nagle R, Prescott N, Wang L, Dragovich L, McElhinny A, Garcia CF, Ranger-Moore J, Free H, Powell W, Loftus M, Pettay J, Gaire F, Roberts C, Dietel M, Roche P, Grogan T, Tubbs R. Silver in situ hybridization (SISH) for determination of HER2 gene status in breast carcinoma: comparison with FISH and assessment of interobserver reproducibility. Am J Surg Pathol. 2010 Jun; 34 (6):767-76
    View PubMed
  64. Subramanian S, Thayanithy V, West RB, Lee CH, Beck AH, Zhu S, Downs-Kelly E, Montgomery K, Goldblum JR, Hogendoorn PC, Corless CL, Oliveira AM, Dry SM, Nielsen TO, Rubin BP, Fletcher JA, Fletcher CD, van de Rijn M. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. J Pathol. 2010 Jan; 220 (1):58-70
    View PubMed
  65. Downs-Kelly E, Shehata BM, Lopez-Terrada D, Weaver J, Patel RM, Hartke M, Tubbs RR, Skacel M, Goldblum JR. The utility of FOXO1 fluorescence in situ hybridization (FISH) in formalin-fixed paraffin-embedded specimens in the diagnosis of alveolar rhabdomyosarcoma. Diagn Mol Pathol. 2009 Sep; 18 (3):138-43
    View PubMed
  66. Downs-Kelly E, Nayeemuddin KM, Albarracin C, Wu Y, Hunt KK, Gilcrease MZ. Matrix-producing carcinoma of the breast: an aggressive subtype of metaplastic carcinoma. Am J Surg Pathol. 2009 Apr; 33 (4):534-41
    View PubMed
  67. Koh PK, Doumit J, Downs-Kelly E, Bronner MP, Salimi R, Fazio VW, Vogel JD. Ileo-anal j-pouch cancer: an unusual case in an unusual location. Tech Coloproctol. 2008 Dec; 12 (4):341-5 Epub 2008 June 10
    View PubMed
  68. Downs-Kelly E, Mendelin JE, Bennett AE, Castilla E, Henricks WH, Schoenfield L, Skacel M, Yerian L, Rice TW, Rybicki LA, Bronner MP, Goldblum JR. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am J Gastroenterol. 2008 Sep; 103 (9):2333-40; quiz 2341 Epub 2008 July 30
    View PubMed
  69. Weaver J, Downs-Kelly E, Goldblum JR, Turner S, Kulkarni S, Tubbs RR, Rubin BP, Skacel M. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol. 2008 Aug; 21 (8):943-9 Epub 2008 May 23
    View PubMed
  70. Downs-Kelly E, Goldblum JR, Patel RM, Weiss SW, Folpe AL, Mertens F, Hartke M, Tubbs RR, Skacel M. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms. Am J Surg Pathol. 2008 Jan; 32 (1):8-13
    View PubMed
  71. Tubbs RR, Hicks DG, Cook J, Downs-Kelly E, Pettay J, Hartke MB, Hood L, Neelon R, Myles J, Budd GT, Moore HC, Andresen S, Crowe JP. Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 Status in adenocarcinoma of the breast: a single institution experience. Diagn Mol Pathol. 2007 Dec; 16 (4):207-10
    View PubMed
  72. Short SM, Yoder BJ, Tarr SM, Prescott NL, Laniauskas S, Coleman KA, Downs-Kelly E, Pettay JD, Choueiri TK, Crowe JP, Tubbs RR, Budd TG, Hicks DG. The expression of the cytoskeletal focal adhesion protein paxillin in breast cancer correlates with HER2 overexpression and may help predict response to chemotherapy: a retrospective immunohistochemical study. Breast J. 2007 Mar-Apr; 13 (2):130-9
    View PubMed
  73. Terry J, Saito T, Subramanian S, Ruttan C, Antonescu CR, Goldblum JR, Downs-Kelly E, Corless CL, Rubin BP, van de Rijn M, Ladanyi M, Nielsen TO. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol. 2007 Feb; 31 (2):240-6
    View PubMed
  74. Tong GX, Goldblum JR, Qiu W, Skacel M, Downs-Kelly E, Contractor S, Levine P. Primary intravascular synovial sarcoma: a disease of young adult women? Report of a case diagnosed by aspiration biopsy and review of the literature. Diagn Cytopathol. 2006 Dec; 34 (12):834-8
    View PubMed
  75. Jeng BH, Downs-Kelly E, Langston RH. Superficial hypertrophic dendritic epitheliopathy occurring before and after penetrating keratoplasty in a patient with psoriasis. Cornea. 2006 Oct; 25 (9):1097-9
    View PubMed
  76. Lam MM, Corless CL, Goldblum JR, Heinrich MC, Downs-Kelly E, Rubin BP. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall. Int J Gynecol Pathol. 2006 Jul; 25 (3):288-92
    View PubMed
  77. West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, Zhu S, Marinelli RJ, De Luca A, Downs-Kelly E, Goldblum JR, Corless CL, Brown PO, Gilks CB, Nielsen TO, Huntsman D, van de Rijn M. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A. 2006 Jan 17; 103 (3):690-5 Epub 2006 Jan 06
    View PubMed
  78. Patel RM, Downs-Kelly E, Weiss SW, Folpe AL, Tubbs RR, Tuthill RJ, Goldblum JR, Skacel M. Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma. Mod Pathol. 2005 Dec; 18 (12):1585-90
    View PubMed
  79. Downs-Kelly E, Pettay J, Hicks D, Skacel M, Yoder B, Rybicki L, Myles J, Sreenan J, Roche P, Powell R, Hainfeld J, Grogan T, Tubbs R. Analytical validation and interobserver reproducibility of EnzMet GenePro: a second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast. Am J Surg Pathol. 2005 Nov; 29 (11):1505-11
    View PubMed
  80. Downs-Kelly E, Yoder BJ, Stoler M, Tubbs RR, Skacel M, Grogan T, Roche P, Hicks DG. The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study. Am J Surg Pathol. 2005 Sep; 29 (9):1221-7
    View PubMed
  81. Dal Canto AJ, Downs-Kelly E, Perry JD. Ptosis and orbital fat prolapse after posterior sub-Tenon's capsule triamcinolone injection. Ophthalmology. 2005 Jun; 112 (6):1092-7
    View PubMed
  82. Mertens F, Fletcher CD, Antonescu CR, Coindre JM, Colecchia M, Domanski HA, Downs-Kelly E, Fisher C, Goldblum JR, Guillou L, Reid R, Rosai J, Sciot R, Mandahl N, Panagopoulos I. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest. 2005 Mar; 85 (3):408-15
    View PubMed
  83. Jones MZ, Alroy J, Downs-Kelly E, Lucas RE, Kraemer SA, Cavanagh KT, King B, Hopwood JJ. Caprine mucopolysaccharidosis IIID: fetal and neonatal brain and liver glycosaminoglycan and morphological perturbations. J Mol Neurosci. 2004; 24 (2):277-91
    View PubMed
  84. Downs-Kelly E, Hoschar AP, Prayson RA. Salivary gland heterotopia in the rectum. Ann Diagn Pathol. 2003 Apr; 7 (2):124-6
    View PubMed
  85. Downs-Kelly E, Jones MZ, Alroy J, Cavanagh KT, King B, Lucas RE, Baker JC, Kraemer SA, Hopwood JJ. Caprine mucopolysaccharidosis IIID: a preliminary trial of enzyme replacement therapy. J Mol Neurosci. 2000 Dec; 15 (3):251-62
    View PubMed